Compositions comprising encapsulated tretinoin

US12357602B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-12357602-B2
Application numberUS-201816033260-A
CountryUS
Kind codeB2
Filing dateJul 12, 2018
Priority dateJul 12, 2017
Publication dateJul 15, 2025
Grant dateJul 15, 2025

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present application is directed to compositions comprising microcapsules comprising encapsulated tretinoin, wherein the microcapsule size is less than 50 μm; and to methods of use thereof.

First claim

Opening claim text (preview).

What is claimed is: 1. A composition comprising: microcapsules comprising tretinoin, wherein: said microcapsules comprise a core containing tretinoin dispersed in an oil and a phase changing material and a metal oxide shell; and wherein said tretinoin is in solid form and said microcapsules have a D 90 between 30 μm to 50 μm; and wherein said tretinoin is in the range of 0.01%-0.1% by weight of the composition; and microcapsules comprising solid benzoyl peroxide with a metal oxide shell; wherein said benzoyl peroxide is in an amount of 3% by weight of the composition; wherein degradation of said tretinoin is less than 2.5% after two weeks storage at 40° C. and 75% relative humidity. 2. The composition according to claim 1 , wherein said tretinoin is in the amount of between 0.05% and 0.1% weight of the composition. 3. The composition according to claim 2 , wherein said tretinoin is in the amount of 0.075% weight of the composition. 4. The composition according to claim 1 , wherein the composition comprises a carrier, wherein the carrier is in the form of an ointment, a cream, a lotion, an oil, a solution, an emulsion, a gel, a paste, a milk, an aerosol, a powder, or a foam. 5. The composition according to claim 1 , wherein the concentration of all-trans 5,6-epoxy retinoic acid after two weeks storage at 40° C. and 75% relative humidity is less than 1% by weight of the initial tretinoin amount prior to storage. 6. The composition according to claim 1 , wherein the degradation of said tretinoin is less than 2%. 7. The composition according to claim 1 , wherein the degradation of said tretinoin is not more than 5% by weight of the initial tretinoin amount, after 18 or 24 months storage at 2° C.-8° C. 8. The composition according to claim 1 , wherein the degradation of said tretinoin is not more than 5% by weight of the initial tretinoin amount, after 3 months storage at 25° C. and 60% RH. 9. The composition according to claim 1 , wherein the composition comprises a carrier, wherein the carrier is in the form of an ointment, a cream, a lotion, an oil, an emulsion, or a gel. 10. The composition according to claim 9 , wherein the amount of said tretinoin is 0.1% weight of the composition and the amount of said benzoyl peroxide is 3% weight of the composition. 11. The composition of claim 1 , wherein said composition has a tretinoin dissolution rate of less than 60% weight/h as measured in a medium of 30%:70% V/V mixture of water and isopropyl alcohol at ambient temperature. 12. The composition according to claim 11 , wherein said composition has a tretinoin dissolution rate of less than 40% weight/h. 13. A method for treating a skin disease, disorder or condition selected from acne, infection, inflammation, pruritus, psoriasis, seborrhea, contact dermatitis, rosacea, melasma, photoaging, photodamage, fine wrinkles, and a combination thereof in a subject in need thereof, said method comprising topically administering to said subject a composition according to claim 1 . 14. A method for treating a skin disease, disorder or condition selected from acne, infection, inflammation, pruritus, psoriasis, seborrhea, contact dermatitis, rosacea, melasma, photoaging, photodamage, fine wrinkles, and a combination thereof in a subject in need thereof, said method comprising topically administering to said subject a composition according to claim 11 .

Assignees

Inventors

Classifications

  • Inorganic compounds · CPC title

  • Emulsions {; Emulsion preconcentrates; Micelles (composition of emulsions A61K47/00)} · CPC title

  • Ointments; Bases therefor; {Other semi-solid forms, e.g. creams, sticks, gels (composition of ointments, creams or gels A61K47/00)} · CPC title

  • Skin, i.e. galenical aspects of topical compositions (non-active ingredients are additionally classified in A61K47/00; A61K9/0009, A61K9/0021, A61K9/7015, A61K9/7023 take precedence; cosmetic preparations A61K8/00, A61Q; preparations for wound dressings or bandages A61L26/00) · CPC title

  • Retinoic acids {; Salts thereof} · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US12357602B2 cover?
The present application is directed to compositions comprising microcapsules comprising encapsulated tretinoin, wherein the microcapsule size is less than 50 μm; and to methods of use thereof.
Who is the assignee on this patent?
Sol Gel Tech Ltd, Mayne Pharma Llc
What technology area does this patent fall under?
Primary CPC classification A61K31/202. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Jul 15 2025 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 11 related publications on this page (citations in our corpus or others sharing the same primary CPC).